Annual Drug Patent Expirations for AUBAGIO
Aubagio is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AUBAGIO.
This drug has seventy-one patent family members in forty-six countries.
The generic ingredient in AUBAGIO is teriflunomide. One supplier is listed for this compound. Additional details are available on the teriflunomide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
